Phreesia, Inc. (NYSE:PHR – Get Free Report) insider David Linetsky sold 2,059 shares of the stock in a transaction on Friday, October 17th. The shares were sold at an average price of $22.36, for a total value of $46,039.24. Following the completion of the sale, the insider owned 171,829 shares of the company’s stock, valued at $3,842,096.44. The trade was a 1.18% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at the SEC website.
David Linetsky also recently made the following trade(s):
- On Thursday, September 18th, David Linetsky sold 93 shares of Phreesia stock. The shares were sold at an average price of $23.94, for a total value of $2,226.42.
- On Wednesday, September 17th, David Linetsky sold 1,064 shares of Phreesia stock. The shares were sold at an average price of $23.50, for a total value of $25,004.00.
- On Tuesday, September 16th, David Linetsky sold 2,165 shares of Phreesia stock. The stock was sold at an average price of $23.28, for a total value of $50,401.20.
- On Friday, August 22nd, David Linetsky sold 17,445 shares of Phreesia stock. The shares were sold at an average price of $29.73, for a total value of $518,639.85.
- On Monday, August 18th, David Linetsky sold 78 shares of Phreesia stock. The shares were sold at an average price of $29.16, for a total value of $2,274.48.
Phreesia Price Performance
NYSE PHR opened at $23.11 on Wednesday. The company has a debt-to-equity ratio of 0.02, a current ratio of 2.12 and a quick ratio of 2.12. The firm has a market capitalization of $1.38 billion, a price-to-earnings ratio of -55.02 and a beta of 0.68. The company has a 50 day simple moving average of $25.92 and a 200-day simple moving average of $25.97. Phreesia, Inc. has a 52-week low of $17.07 and a 52-week high of $32.76.
Analyst Ratings Changes
Several analysts recently issued reports on the company. DA Davidson upgraded Phreesia to a “strong-buy” rating in a report on Monday, September 8th. KeyCorp cut their price target on Phreesia from $35.00 to $32.00 and set an “overweight” rating for the company in a research note on Wednesday, October 8th. Piper Sandler boosted their price target on Phreesia from $33.00 to $34.00 and gave the company an “overweight” rating in a research note on Friday, September 5th. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Phreesia in a research report on Wednesday, October 8th. Finally, Canaccord Genuity Group increased their price target on shares of Phreesia from $34.00 to $38.00 and gave the stock a “buy” rating in a research note on Friday, September 5th. One equities research analyst has rated the stock with a Strong Buy rating, twelve have assigned a Buy rating and one has given a Sell rating to the stock. According to MarketBeat, Phreesia presently has a consensus rating of “Moderate Buy” and a consensus target price of $33.85.
View Our Latest Analysis on Phreesia
Hedge Funds Weigh In On Phreesia
Several hedge funds and other institutional investors have recently added to or reduced their stakes in PHR. KBC Group NV acquired a new stake in shares of Phreesia in the first quarter worth $74,000. Farther Finance Advisors LLC raised its holdings in Phreesia by 9,375.0% in the 2nd quarter. Farther Finance Advisors LLC now owns 3,032 shares of the company’s stock worth $86,000 after acquiring an additional 3,000 shares during the period. CWM LLC lifted its position in Phreesia by 994.9% during the 1st quarter. CWM LLC now owns 4,040 shares of the company’s stock worth $103,000 after acquiring an additional 3,671 shares during the last quarter. Smartleaf Asset Management LLC lifted its position in Phreesia by 53.0% during the 1st quarter. Smartleaf Asset Management LLC now owns 5,267 shares of the company’s stock worth $137,000 after acquiring an additional 1,825 shares during the last quarter. Finally, GAMMA Investing LLC boosted its holdings in Phreesia by 10,605.7% during the first quarter. GAMMA Investing LLC now owns 5,674 shares of the company’s stock valued at $145,000 after acquiring an additional 5,621 shares during the period. Institutional investors and hedge funds own 92.10% of the company’s stock.
About Phreesia
Phreesia, Inc provides an integrated SaaS-based software and payment platform for the healthcare industry in the United States and Canada. The company offers access solutions that offers appointment scheduling system for online appointments, reminders, and referral tracking management; registration solution to automate patient self-registration; revenue cycle solution, which offer insurance-verification processes, point-of-sale payments applications, post-visit payment collection, and flexible payment options; and network connect solution to deliver clinically relevant content to patients.
Featured Articles
- Five stocks we like better than Phreesia
- What does consumer price index measure?
- 2 Ways to Trade Qualcomm Ahead of November’s Earnings
- What is an Earnings Surprise?
- Lululemon: 2 Signs the Bottom Is In, and 1 Sign It Isn’t
- How to Calculate Retirement Income: MarketBeat’s Calculator
- Got 1K to Invest? These 3 Stocks Are Still Attractive Buys
Receive News & Ratings for Phreesia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Phreesia and related companies with MarketBeat.com's FREE daily email newsletter.